|
|
|
|
Assessment of Failures of Long-Acting Cabotegravir and Rilpivirine in a Real-World Treatment Setting
|
|
|
IDWeek 2024 Oct 16-19 LA, CA
Nicholas Yared1; Smitha Gudipati1; Shannon Payne1; Indira Brar1
Department of Infectious Disease, Henry Ford Health, Detroit, MI
|
|
|
|
|
|
|